OptimizeRx Corp — Director's Dealing 2014

May 22, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2014-05-19

Reporting Person: BAKER DOUGLAS P (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$1.72	2020-05-12	Common Stock (100000)		Direct

Footnotes

F1: The Stock Options will vest as to 50% of the shares on May 12, 2015 and 50% of the shares on May 12, 2016.